Related Experiment Video
Updated: Dec 14, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Decreased Mitochondrial DNA Content Drives OXPHOS Dysregulation in Chromophobe Renal Cell Carcinoma
Yi Xiao1,2, Rosanna Clima3,4, Jonas Busch5
1Max Planck Institute for Molecular Genetics, Berlin, Germany.
Abstract:
Chromophobe renal cell carcinoma (chRCC) and renal oncocytoma are closely related, rare kidney tumors. Mutations in complex I (CI)-encoding genes play an important role in dysfunction of the oxidative phosphorylation (OXPHOS) system in renal oncocytoma, but are less frequently observed in chRCC. As such, the relevance of OXPHOS status and role of CI mutations in chRCC remain unknown. To address this issue, we performed proteome and metabolome profiling as well as mitochondrial whole-exome sequencing to detect mitochondrial alterations in chRCC tissue specimens. Multiomic analysis revealed downregulation of electron transport chain (ETC) components in chRCC that differed from the expression profile in renal oncocytoma. A decrease in mitochondrial (mt)DNA content, rather than CI mutations, was the main cause for reduced OXPHOS in chRCC. There was a negative correlation between protein and transcript levels of nuclear DNA- but not mtDNA-encoded ETC complex subunits in chRCC. In addition, the reactive oxygen species scavenger glutathione (GSH) was upregulated in chRCC due to decreased expression of proteins involved in GSH degradation. These results demonstrate that distinct mechanisms of OXPHOS exist in chRCC and renal oncocytoma and that expression levels of ETC complex subunits can serve as a diagnostic marker for this rare malignancy. SIGNIFICANCE: These findings establish potential diagnostic markers to distinguish malignant chRCC from its highly similar but benign counterpart, renal oncocytoma.
Insights
Chromophobe renal cell carcinoma (chRCC) exhibits distinct oxidative phosphorylation (OXPHOS) mechanisms compared to renal oncocytoma. Reduced mitochondrial DNA content, not Complex I mutations, causes OXPHOS dysfunction in chRCC, offering potential diagnostic markers.
Area of Science:
- * Renal cell carcinoma research
- * Cancer genomics
- * Mitochondrial biology
Background:
- * Chromophobe renal cell carcinoma (chRCC) and renal oncocytoma are rare, similar kidney tumors.
- * Complex I (CI) mutations impact oxidative phosphorylation (OXPHOS) in renal oncocytoma but are less common in chRCC.
- * The role of OXPHOS and CI mutations in chRCC pathogenesis is largely unknown.
Purpose of the Study:
- * To investigate the role of mitochondrial alterations and OXPHOS dysfunction in chRCC.
- * To compare the molecular mechanisms of OXPHOS between chRCC and renal oncocytoma.
- * To identify potential diagnostic markers for chRCC.
Main Methods:
- * Proteome and metabolome profiling of chRCC tissue specimens.
- * Mitochondrial whole-exome sequencing.
- * Multiomic analysis integrating proteomic, metabolomic, and genomic data.
Main Results:
- * chRCC displayed downregulated electron transport chain (ETC) components, differing from renal oncocytoma.
- * Decreased mitochondrial (mt)DNA content, not CI mutations, was the primary cause of reduced OXPHOS in chRCC.
- * Glutathione (GSH) was upregulated in chRCC due to reduced expression of GSH-degrading proteins.
- * Negative correlation observed between protein and transcript levels of nuclear-encoded ETC subunits.
Conclusions:
- * Distinct mechanisms underlie OXPHOS dysfunction in chRCC versus renal oncocytoma.
- * Mitochondrial DNA content is a key factor in chRCC OXPHOS impairment.
- * ETC complex subunit expression levels can serve as diagnostic markers to differentiate chRCC from renal oncocytoma.
More Related Videos
09:16Real-Time Analysis of Bioenergetics in Primary Human Retinal Pigment Epithelial Cells Using High-Resolution Respirometry
Published on: February 3, 2023
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Abnormal Proliferation
Mitochondria
Animal Mitochondrial Genetics